Researchers developed a retron-based system that enables DNA to function as an active intracellular tool rather than merely ...
Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene ...
Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
Morning Overview on MSN
DNA-based system targets cancer cells and releases drugs at tumors
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a ...
Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...
In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as pivotal players, offering new avenues for understanding the fine-tuned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results